Insider Transactions in Q3 2024 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.24%
|
$260,000
$52.14 P/Share
|
|
Sep 30
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.23%
|
$30,000
$6.67 P/Share
|
|
Sep 17
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.88%
|
$408,800
$56.76 P/Share
|
|
Sep 17
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.97%
|
$37,100
$7.96 P/Share
|
|
Sep 16
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.24%
|
$275,000
$55.99 P/Share
|
|
Sep 16
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.23%
|
$30,000
$6.67 P/Share
|
|
Sep 09
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$270,000
$54.92 P/Share
|
|
Sep 09
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$105,000
$21.61 P/Share
|
|
Sep 03
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,384
-2.9%
|
$420,888
$57.01 P/Share
|
|
Sep 03
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.97%
|
$37,100
$7.96 P/Share
|
|
Sep 03
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.24%
|
$285,000
$57.03 P/Share
|
|
Sep 03
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.23%
|
$30,000
$6.67 P/Share
|
|
Aug 30
2024
|
Brett A Pletcher EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,140
+50.0%
|
-
|
|
Aug 26
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$285,000
$57.26 P/Share
|
|
Aug 26
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$105,000
$21.61 P/Share
|
|
Aug 20
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.82%
|
$408,800
$56.24 P/Share
|
|
Aug 20
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.91%
|
$37,100
$7.96 P/Share
|
|
Aug 19
2024
|
Robert I Blum President & CEO |
SELL
Bona fide gift
|
Direct |
1,956
-0.49%
|
-
|
|
Aug 12
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$275,000
$55.2 P/Share
|
|
Aug 12
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$105,000
$21.61 P/Share
|
|
Aug 12
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
11,500
-2.8%
|
$632,500
$55.17 P/Share
|
|
Aug 12
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+2.72%
|
$69,000
$6.67 P/Share
|
|
Aug 07
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+4.01%
|
$37,100
$7.96 P/Share
|
|
Aug 06
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.86%
|
$386,900
$53.72 P/Share
|
|
Jul 30
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
11,500
-2.8%
|
$678,500
$59.49 P/Share
|
|
Jul 30
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+2.72%
|
$69,000
$6.67 P/Share
|
|
Jul 29
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$295,000
$59.84 P/Share
|
|
Jul 29
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$105,000
$21.61 P/Share
|
|
Jul 23
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.74%
|
$416,100
$57.02 P/Share
|
|
Jul 23
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.8%
|
$37,100
$7.96 P/Share
|
|
Jul 15
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$275,000
$55.82 P/Share
|
|
Jul 15
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$50,000
$10.68 P/Share
|
|
Jul 10
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
11,500
-2.8%
|
$621,000
$54.29 P/Share
|
|
Jul 10
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,767
+1.38%
|
$34,602
$6.67 P/Share
|
|
Jul 09
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.67%
|
$401,500
$55.9 P/Share
|
|
Jul 09
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.69%
|
$37,100
$7.96 P/Share
|
|
Jul 05
2024
|
Robert Arthur Harrington Director |
SELL
Open market or private sale
|
Direct |
253
-1.6%
|
$13,662
$54.61 P/Share
|
|
Jul 01
2024
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
114
+0.46%
|
-
|
|
Jul 01
2024
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
114
+0.5%
|
-
|
|
Jul 01
2024
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
228
+1.43%
|
-
|
|
Jul 01
2024
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
388
+1.01%
|
-
|
|
Jul 01
2024
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
228
+0.9%
|
-
|
|
Jul 01
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$270,000
$54.22 P/Share
|
|
Jul 01
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$50,000
$10.68 P/Share
|
|
Jul 01
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
11,500
-2.76%
|
$621,000
$54.05 P/Share
|